EPIQ Capital Group »

Bridgebio Pharma shares owned by EPIQ Capital Group

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by EPIQ Capital Group from 13F filings

Historical chart of EPIQ Capital Group investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by EPIQ Capital Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by EPIQ Capital Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $414k 16k 25.46

More positions owned by EPIQ Capital Group

Ishares Tr Rus 1000 Etf (IWB)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Msci Acwi Etf (ACWI)
Ishares Gold Tr Ishares New (IAU)
Meta Platforms Cl A (META)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr Gold Tr Gold Shs (GLD)
Rubrik Cl A (RBRK)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Applovin Corp Com Cl A (APP)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alibaba Group Hldg Sponsored Ads (BABA)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)

View all positions for EPIQ Capital Group

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
BlackRock
BlackRock
Aisling Capital Management
State Street Corporation
Susquehanna International
Henderson Group
Laurion Capital Management
Frazier Life Sciences Management
Geode Capital Management
Citadel Advisors
Pictet Asset Management Holding SA
Jane Street

View all funds holding Bridgebio Pharma